yingweiwo

Benzoic acid

Alias: Benzoic acid; Benzoesaeure; Benzenecarboxylic acid; Benzeneformic acid;
Cat No.:V10921 Purity: ≥98%
Benzoic acid is a novel and potent fungistatic compound.
Benzoic acid
Benzoic acid Chemical Structure CAS No.: 65-85-0
Product category: Bacterial
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
2g
5g
10g
Other Sizes

Other Forms of Benzoic acid:

  • Benzoic acid lithium (lithium benzoate)
  • 2-Hydroxy-5-(phenyldiazenyl)benzoic acid-d5
  • 3-(N-Phenylsulfamoyl)benzoic acid-d5
  • Benzoic acid-d5
  • 3,6-Dichloro-2-hydroxybenzoic acid-13C6
  • 4-Aminobenzoic acid-13C6 (PABA-13C6; Vitamin Bx-13C6; Vitamin H1-13C6; p-Aminobenzoic acid-13C6)
  • 2-Chlorobenzoic acid-13C6
  • 2-Methoxybenzoic acid-13C6
  • 4-Fluorobenzoic acid-13C6
  • Benzoic acid-13C6
  • Benzoic-3,5 Acid-d2 (lithium benzoate-d2)
  • 2-Chlorobenzoic Acid-13C7
  • Benzoic acid-13C
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Product Description
Benzoic acid is an aromatic alcohol existing naturally in many plants and is a common additive to food, drinks, cosmetics and other products.It functions as a preservative by preventing the growth of fungi and bacteria.
Biological Activity I Assay Protocols (From Reference)
Targets
Microbial Metabolite
ln Vitro
OAT2-catalyzed efflux of glutamic acid and orotic acid from 293 cells expressing OAT2h is stimulated by benzoic acid (1 mM)[2].
Antibacterial activity of benzoic acid (0.5 and 2.0 mg/disc) against S. aureus, S. epidermidis, P. aeruginosa, and B. cereu) has been reported[4].
ln Vivo
Combining thymol (HY-N6810) (100 mg/kg in diet, 1–14 days) with benzoic acid (2,000 mg/kg in diet) enhances growth performance, increases nutrient absorption and digestion, and lessens diarrhea in weaned pigs[3].
ADME/Pharmacokinetics
Absorption, Distribution and Excretion
Following oral administration of benzoic acid and sodium benzoate, they are rapidly absorbed (undissociated benzoic acid) from the gastrointestinal tract of experimental animals or humans. …Absorption can be considered to be 100%. In humans, peak plasma concentrations are reached within 1–2 hours. Distribution and elimination experiments of 14C-benzoate in rats showed no accumulation of sodium benzoate or benzoic acid in the body. Benzoic acid and sodium benzoate are rapidly absorbed from the gastrointestinal tract of mammals and bind to glycine in the liver. The resulting hippuric acid is rapidly excreted in the urine (75% to 100% of the dose is excreted within 6 hours; the remaining dose is excreted within 2 to 3 days). Researchers reported that 42.6% ± 16.5% of the dermatologically applied dose of (14)C-benzoic acid (4 μg/cm²; soluble in acetone) was excreted in the urine within 24 hours. When used in combination with petrolatum, 60.5% of the dose is absorbed. For more complete data on the absorption, distribution, and excretion of benzoic acids (17 in total), please visit the HSDB records page. Metabolites/Metabolites Benzoic acid…combines with glycine to form hippuric acid…in many mammals (humans, monkeys, pigs, rabbits, rodents, cats, dogs, ferrets, and hedgehogs). Dogs, ferrets, and hedgehogs also excrete…benzoyl glucuronide…but Indian fruit bats excrete almost all doses as benzoyl glucuronide. Researchers have demonstrated that the bioconversion of benzoic acid to hippuric acid after ingestion of sodium benzoate in humans follows saturated or Michaelis kinetics. Sodium benzoate. Glycine availability is the rate-limiting factor in hippuric acid formation. When glycine is insufficient, benzoyl glucuronide is formed. Researchers report that both lipoic acid and valproic acid can reduce the clearance of benzoic acid in rats already "loaded" with glycine. Both acids reduce the availability of coenzyme A in the liver, which is essential for the ATP-dependent binding of benzoic acid to glycine. For more complete data on the metabolism/metabolites of benzoic acid (11 metabolites in total), please visit the HSDB record page. Known human metabolites of benzoic acid include benzoyl glucuronide.
Toxicity/Toxicokinetics
Toxicity Data
LC50 (Rat) => 26 mg/m³/1H
References

[1]. Final report on the safety assessment of Benzyl Alcohol, Benzoic Acid, and Sodium Benzoate. Int J Toxicol. 2001;20 Suppl 3:23-50.

[2]. Benzoic acid and specific 2-oxo acids activate hepatic efflux of glutamate at OAT2. Biochim Biophys Acta. 2013 Feb;1828(2):491-8.

[3]. Effects of benzoic Acid and thymol on growth performance and gut characteristics of weaned piglets. Asian-Australas J Anim Sci. 2015 Jun;28(6):827-39.

[4]. Simultaneous Determination of Benzoic Acid, Caffeic Acid and Chlorogenic Acid in Seeds of Eriobotrya japonica and their Antibacterial Effect.Journal of Applied Biological Chemistry. Volume 57 Issue 1. Pages.89-93 / 2014 / 1976-0442(pISSN) / 2234-7941(eISSN).

Additional Infomation
Benzoic acid is a white crystalline solid, slightly soluble in water. Its main hazard lies in the potential environmental damage it may cause upon release. Immediate measures should be taken to limit its spread into the environment. Benzoic acid can be used in the manufacture of other chemicals, as a food preservative, and for other purposes. Benzoic acid is a compound composed of a benzene ring core and carboxylic acid substituents. It has multiple functions, including as an antimicrobial food preservative, an EC 3.1.1.3 (triacylglycerol lipase) inhibitor, an EC 1.13.11.33 (arachidonic acid 15-lipoxygenase) inhibitor, a plant metabolite, a human exogenous substance metabolite, an algal metabolite, and a drug allergen. It is the conjugate acid of benzoate. Benzoic acid is a widely used antimicrobial compound as a food preservative. It binds to glycine in the liver and is excreted as hippuric acid. Sodium benzoate, as its sodium salt form, can be used to treat urea cycle disorders because it can bind to amino acids. This leads to the excretion of amino acids, thereby lowering ammonia levels. Recent studies suggest that sodium benzoate (1 gram daily) may be effective as adjunctive therapy for schizophrenia. Compared to placebo, it reduced the total score on the Positive and Negative Syndrome Scale by 21%. Benzoic acid is a nitrogen-binding agent. Its mechanism of action is the binding of ammonium ions. Benzoic acid has been reported in chrysanthemum, peony, and other organisms with relevant data. Benzoic acid (C6H5COOH) is a colorless crystalline solid and the simplest aromatic carboxylic acid. It exists naturally in many plant and animal species in both free and benzoic acid ester forms. Most berries contain a significant amount of benzoic acid (approximately 0.05%). Cranberries contain up to 300-1300 mg of free benzoic acid per kilogram of fruit. Benzoic acid is an antibacterial compound widely used as a food preservative. It is normally bound to glycine in the liver and excreted as hippuric acid. Benzoic acid is a byproduct of phenylalanine metabolism in bacteria. It is also produced when intestinal bacteria process polyphenols (from ingested fruits or beverages).
A widely used antibacterial compound as a food preservative. It binds to glycine in the liver and is excreted as hippuric acid.
See also: salicylic acid (active ingredient); benzoyl peroxide (active ingredient); sodium benzoate (active ingredient)...See more...
Therapeutic Uses
Antifungal agent; food preservative
Benzoic acid...has long been used as an antifungal agent in topical treatments, such as Whitfield ointment (6% benzoic acid and 3% salicylic acid).
...It is used particularly for the treatment of athlete's foot, and secondarily for the treatment of tinea corporis.
Veterinary medicine: It has been used in combination with salicylic acid as a topical antifungal agent.
/Experimental therapy:/This invention discloses a method for controlling diseases of waste nitrogen accumulation in the human body by administering at least one compound selected from benzoic acid, phenylacetic acid, and their salts. Administration of sodium benzoate (6.2 g/day) to female patients with carbophosphate synthase deficiency resulted in a 58% increase in total urinary nitrogen excretion.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C7H6O2
Molecular Weight
122.12
Exact Mass
122.036
Elemental Analysis
C, 68.85; H, 4.95; O, 26.20
CAS #
65-85-0
Related CAS #
Benzoic acid lithium;553-54-8;Benzoic acid-d5;1079-02-3;Benzoic acid-13C6;125945-98-4;Benzoic-3,5 Acid-d2;37960-84-2;Benzoic acid-13C;3880-99-7
PubChem CID
243
Appearance
White to off-white solid powder
Density
1.2±0.1 g/cm3
Boiling Point
249.3±9.0 °C at 760 mmHg
Melting Point
121-125 °C(lit.)
Flash Point
121.1±0.0 °C
Vapour Pressure
0.0±0.5 mmHg at 25°C
Index of Refraction
1.564
LogP
1.89
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Rotatable Bond Count
1
Heavy Atom Count
9
Complexity
104
Defined Atom Stereocenter Count
0
SMILES
O([H])C(C1C([H])=C([H])C([H])=C([H])C=1[H])=O
InChi Key
WPYMKLBDIGXBTP-UHFFFAOYSA-N
InChi Code
InChI=1S/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9)
Chemical Name
benzoic acid
Synonyms
Benzoic acid; Benzoesaeure; Benzenecarboxylic acid; Benzeneformic acid;
HS Tariff Code
2934.99.03.00
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO : 24~100 mg/mL ( 196.52~818.87 mM )
H2O: ~7.14 mg/mL (~58.47 mM )
Ethanol : ~24 mg/mL
Solubility (In Vivo)
Solubility in Formulation 1: ≥ 2.5 mg/mL (20.47 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (20.47 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

View More

Solubility in Formulation 3: ≥ 2.5 mg/mL (20.47 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.


Solubility in Formulation 4: 10% DMSO+40% PEG300+5% Tween-80+45% Saline: ≥ 2.5 mg/mL (20.47 mM)

Solubility in Formulation 5: 4.55 mg/mL (37.26 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with ultrasonication (<60°C).

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 8.1887 mL 40.9433 mL 81.8867 mL
5 mM 1.6377 mL 8.1887 mL 16.3773 mL
10 mM 0.8189 mL 4.0943 mL 8.1887 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Clinical Trial Information
NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT03190785 Completed Other: Benzoic acid washout and exposure Metabolic Syndrome
Obesity
East Carolina University 2017-07-01 Not Applicable
NCT01527123 Completed Drug: GSK2585823 Acne Vulgaris GlaxoSmithKline 2012-02-28 Phase 1
NCT05938452 Completed Drug: Glyceryl Tribenzoate Neurological Disorder Forest Hills Lab 2022-12-12 Phase 1
NCT04939623 Recruiting Drug: Probenecid Chronic Pain
Drug Dependence of Morphine Type
Symptom, Withdrawal
University of Calgary 2023-10-31 Phase 2
NCT00624676 Unknown status Drug: Lipo Hydroxy Acid
Drug: 5% benzoyl peroxide gel
Acne Vulgaris Cosmetique Active International 2006-01 Not Applicable
Biological Data
  • Benzoic acid stimulates efflux of glutamic acid and orotic acid from OAT2h-expressing cells. [2]. Benzoic acid and specific 2-oxo acids activate hepatic efflux of glutamate at OAT2. Biochim Biophys Acta. 2013 Feb;1828(2):491-8.
  • Time course — benzoic acid stimulates OAT2h-catalyzed glutamate efflux.[2]. Benzoic acid and specific 2-oxo acids activate hepatic efflux of glutamate at OAT2. Biochim Biophys Acta. 2013 Feb;1828(2):491-8.
  • Benzoic acid is not transported by OAT2.[2]. Benzoic acid and specific 2-oxo acids activate hepatic efflux of glutamate at OAT2. Biochim Biophys Acta. 2013 Feb;1828(2):491-8.
  • Concurrent incubation with orotic acid and benzoic acid does not increase efflux of 3H-orotic acid further. [2]. Benzoic acid and specific 2-oxo acids activate hepatic efflux of glutamate at OAT2. Biochim Biophys Acta. 2013 Feb;1828(2):491-8.
  • EC50 of benzoic acid for stimulation of glutamate efflux differs from Ki for inhibition of uptake of orotic acid. [2]. Benzoic acid and specific 2-oxo acids activate hepatic efflux of glutamate at OAT2. Biochim Biophys Acta. 2013 Feb;1828(2):491-8.
Contact Us